CRT Capital Upgrades Edwards Lifesciences (EW) to Buy
Tweet
Share
E-mailGet Alerts EW Hot Sheet
Price: $90.05 +0.95%
Rating Summary:
23 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 51
Rating Summary:
23 Buy, 18 Hold, 2 Sell
Rating Trend:
Up
Today's Overall Ratings:
Up: 11 | Down: 14 | New: 51
Join SI Premium – FREE
CRT Capital upgraded Edwards Lifesciences (NYSE: EW) from Fairly Valued to Buy with a price target of $87.00.
For an analyst ratings summary and ratings history on Edwards Lifesciences click here. For more ratings news on Edwards Lifesciences click here.
Shares of Edwards Lifesciences closed at $72.97 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Stifel Upgrades Barry Callebaut AG (BARN:SW) (BYCBF) to Buy
- Piper Sandler Upgrades CNO Financial Group (CNO) to Overweight
- Baird Upgrades Crown Holdings (CCK) to Outperform, 'an unsustainable valuation spread'
Create E-mail Alert Related Categories
Analyst PT Change, UpgradesSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
